Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.265    -0.005 (-1.85%)
Bid:
0.25
Ask:
0.28
Spread: 0.03 (12.00%)
Market Cap: £15.36m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Trading Update

7 May 2024 07:00

RNS Number : 3875N
CAP-XX Limited
07 May 2024
 

Dissemination of a Regulatory Announcement that contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

7 May 2024

CAP-XX Limited

("CAP-XX" or the "Company")

Trading update

CAP-XX Limited, a world leader in the design and manufacture of supercapacitors and energy management systems, provides the following update.

Following the successful completion of the recent fundraise, the Board is pleased to announce that current trading on existing products remains strong, in line with management forecasts, and trial shipments of pre-samples of new product have recently commenced. Bookings and billings are 14% and 56% ahead respectively for the year to date compared to the comparative period in 2023, along with a current book to bill ratio of 1.12. The order backlog remains strong at close to US$1 million.

 

As previously stated, the proceeds from the fundraise are being used to improve the Company's financial position and provide working capital for investment. Key areas for investment include the continued expansion of the sales representative and distribution network, and working capital for the market introduction of the new DMH and SMD products. The vast bulk of the development costs of the latter has already been incurred, although some final commissioning of the DMH production line remains. An initial pre-series batch of fully functional DMH product is currently under lab evaluation and SMD testing remains on track. In addition, the Company expects to announce further patents during the next three months.

 

The Board considers that, apart from the final settlement of legal costs associated with the Maxwell/Tesla litigation, which it does not consider material, the only remaining payments for legal costs will be normal ongoing corporate legal expenses, including, for example, those associated with applications for patents.

 

In addition, the Company has implemented a comprehensive cost reduction program, which has delivered annualised operating cost savings in excess of US$0.5 million, and is expected to ensure that CAP-XX successfully overcomes its recent challenging phase.

 

The target for breakeven remains in the 2026 calendar year, assuming billings maintain their current growth trend. This is being supported by the recent investment in CAP-XX's international direct sales and marketing, the expansion of the distributor network, together with design wins and billings from our new product families, DMH and SMD, which will contribute in 2025 and 2026 respectively.

 

Following the conclusion of the financial year ending 30 June 2024, CAP-XX intends to provide a comprehensive update to investors on products and markets and corporate strategy at a Capital Markets seminar, which will be hosted on-line, details of which will be issued in due course.

 

Lars Stegmann, Chief Executive of CAP-XX, said "I'd like to thank our shareholders for their continued support. We look forward to the next exciting phase for the Company, as we prepare for our new product launches, supported by a strengthening sales and distribution team. We believe this has the potential to transform the commercial success of CAP-XX."

 

 

For further information contact:

CAP-XX Limited

Pat Elliott (Chairman) +61 (2) 9157 0000

Lars Stegmann (Chief Executive Officer)

 

Allenby Capital (Nominated Adviser and Joint Broker)

David Hart / Piers Shimwell (Corporate Finance)  +44 (0) 20 3328 5656

Tony Quirke / Stefano Aquilino (Sales and Corporate Broking)

 

Cavendish Securities plc (Joint Broker)

Neil McDonald / Pearl Kellie +44 (0) 13 1220 6939

 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

 

 

Notes to Editors:

CAP-XX (LSE: CPX) is a leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUUCAUPCUAM
Date   Source Headline
23rd Apr 202110:21 amRNSAppointment of Joint Broker
30th Mar 20217:00 amRNSNotification of transactions by PDMRs
23rd Mar 20217:00 amRNSHolding(s) in Company
16th Mar 20214:40 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
15th Mar 20217:00 amRNSPortal Instruments Selects CAP-XX Supercapacitors
25th Feb 20217:00 amRNSInterim Results
16th Feb 202112:55 pmRNSLight energy harvesting evaluation modules
9th Feb 20217:00 amRNSTrading update and notification of date of results
5th Jan 20219:06 amRNSHolding(s) in Company
4th Jan 20217:15 amRNSUpdate re Tax Rebate
31st Dec 202011:31 amRNSHolding(s) in Company
22nd Dec 202011:05 amRNSSecond Price Monitoring Extn
22nd Dec 202011:00 amRNSPrice Monitoring Extension
22nd Dec 20207:00 amRNSProduct shipped from new production lines
18th Dec 20207:00 amRNSHolding(s) in Company
10th Dec 20208:02 amRNSExercise of employee share options
30th Nov 20207:00 amRNSHolding(s) in Company
25th Nov 20208:15 amRNSResult of AGM and Chairman’s AGM statement
3rd Nov 202012:49 pmRNSReplacement: Audited results
3rd Nov 20207:00 amRNSAudited results for the year ended 30 June 2020
23rd Oct 20207:00 amRNSNotice of Results
8th Oct 20207:00 amRNSAward of LSE Green Economy Mark
10th Sep 20207:11 amRNSCorporate update
26th Aug 20208:23 amRNSHolding(s) in Company
25th Aug 202010:21 amRNSIssue of Shares
21st Aug 20204:41 pmRNSSecond Price Monitoring Extn
21st Aug 20204:36 pmRNSPrice Monitoring Extension
21st Aug 202011:05 amRNSSecond Price Monitoring Extn
21st Aug 202011:00 amRNSPrice Monitoring Extension
17th Aug 20207:35 amRNSHolding(s) in Company
7th Aug 20203:18 pmRNSIoxus intellectual property judgement
26th Jun 20207:28 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jun 20208:57 amRNSChange of Auditor
19th May 20207:00 amRNSTrading Update
29th Apr 20202:06 pmRNSSecond Price Monitoring Extn
29th Apr 20202:01 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSInterim Results
4th Mar 20207:00 amRNSNotification of date of interim results and update
7th Jan 20207:00 amRNSHolding(s) in Company
6th Jan 20208:22 amRNSHolding(s) in Company
30th Dec 20198:30 amRNSResult of General Meeting
24th Dec 20197:00 amRNSResult of Offer to Qualifying Participants
29th Nov 20199:57 amRNSReplacement: Proposed Acquisition and Fundraising
29th Nov 20197:00 amRNSProposed Acquisition from Murata and Fundraising
28th Nov 20198:53 amRNSResult of AGM
13th Nov 20197:00 amRNSNotice of AGM
8th Nov 20197:00 amRNSAudited results for the year ended 30 June 2019
11th Sep 20197:00 amRNSHolding(s) in Company
31st Jul 20198:48 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.